Viewing Study NCT02249351


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-02-22 @ 6:32 AM
Study NCT ID: NCT02249351
Status: TERMINATED
Last Update Posted: 2014-09-26
First Post: 2014-09-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer Disease View
Keywords: